ArticleEuropean journal of heart failure2020

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.

Alexander R Lyon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.